Quick Takeaways
- BlackRock, Inc. filed SCHEDULE 13G for Protara Therapeutics, Inc. Common Stock (TARA).
- Disclosed ownership: 6.3%.
- Date of event: 31 Mar 2026.
BlackRock, Inc. - 31 Mar 2026 SCHEDULE 13G Report for Protara Therapeutics, Inc. Common Stock (TARA)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Symbol
- TARA
- Shares outstanding
- 53,769,190 shares
- Disclosed Ownership
- 3,387,459 shares
- Ownership
- 6.3%
- Form type
- SCHEDULE 13G
- Filing time
- 27 Apr 2026, 16:12:23 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 21 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock, Inc. disclosed 6.3% ownership in Protara Therapeutics, Inc. Common Stock (TARA) on 31 Mar 2026."
What Changed
- Previous schedule filing date: 21 Jan 2026.
- Current filing was accepted on 27 Apr 2026, 16:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 6.3% | 3,387,459 | 3,347,945 | 0 | Spencer Fleming | Managing Director |